HATCHERY ▶▶▶
Preventing cracks and loss- es is essential given that vac- cine eggs are a high value product.
protected by natural biological barriers. Globoaves applies very high standards of sanitary control, using the most mod- ern methods in poultry production with strict controls, such as ventilation control, air conditioning, lighting, automatic nests and plastic slats, as well as in the transport and packag- ing of its eggs on automated lines. The hatcheries have state- of-the-art machines and strict production control with very high sanitary control and good manufacturing practices. It has highly qualified personnel dedicated solely to these as- pects. The feed factories have strict quality and raw material control. The feed provided to the birds is exclusive with its own formula and produced using the best ingredients from recognised and previously selected suppliers to guarantee a specific nutritional content and quality for egg production. All the production steps and raw materials used are traceable for complete process security. The feed is transported in dedi- cated own trucks directly from the factories to the farms. All of this without neglecting the animal welfare aspects which, in both the breeding and production phases, are high priority so the birds can produce eggs of the best quality and in good health. The bird strains used come from the best genetics companies in the world and have been genetically adapted for this purpose.”
Attuned to the flu The whole production process at Pluma is attuned to the human influenza season. “Rearing starts in January and at
16 ▶ POULTRY WORLD | No. 3, 2020
the age of 14 weeks the birds are transfered in May to the production farm,” Kleber explains. “In September we pro- duce the best eggs which we can deliver to the Butantan In- stitute. Production stops in April, after which the houses are cleaned for a new flock in September.” This means the hatchery is only in operation from September to April, pro- ducing eggs for the flu season in the Southern Hemisphere. Globoaves manager Mario Tremarin believes that vaccine egg production in Brazil will grow annually to meet the goals of Brazil’s Ministry of Health and WHO (the World Health Organization). “We have an industry that has a prov- en track record as a responsible partner in the food industry, with technological excellence in genetics, handling and bi- osecurity guaranteing the production of high quality eggs. The country is also free of Avian Influenza and has large are- as of land available on which to build farms with sanitary security and natural biological barriers. We will follow the expansion plans already announced by the Butantan Insti- tute. Globoaves’ production started in 2007 with about 20 million vaccine eggs delivered to the Butantan Institute. To- day the forecast for the 2019/2020 period is to deliver 75 million fertile eggs, which represents a significant increase. Globobiotech has committed to the Butatan Institute that over the coming years it will evolve and grow to meet the expected demand. So we will continue to invest in knowl- edge, new facilities and the latest equipment available on the market.”
PHOTO: FABIAN BROCKOTTER
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36
